世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Europe Epilepsy Drugs Market Forecast to 2030 - Regional Analysis - by Treatment (First Generation Anti-Epileptics, Second Generation Anti-Epileptics, and Third Generation Anti-Epileptics) and Distribution Channel (Hospital Pharmacy, Retail Pharmacy Stores, and Others)


The Europe epilepsy drugs market was valued at US$ 1,941.16 million in 2022 and is expected to reach US$ 2,626.05 million by 2030; it is estimated to grow at a CAGR of 3.8% from 2022 to 2030. I... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
The Insight Partners
ザ・インサイトパートナーズ
2024年3月14日 US$3,550
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
74 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

Summary

The Europe epilepsy drugs market was valued at US$ 1,941.16 million in 2022 and is expected to reach US$ 2,626.05 million by 2030; it is estimated to grow at a CAGR of 3.8% from 2022 to 2030.

Increasing Number of Elderly People Fuels the Europe Epilepsy Drugs Market

Epilepsy is one of the prevalent neurological disorders affecting the geriatric population. According to the National Center for Biotechnology Information, epilepsy is the third most common neurological disorder affecting the elderly after dementia and stroke. The incidence of epilepsy is increasing in older adults, partly because of the growing prevalence of stroke, brain tumors, and dementia. Considering that modern society is aging, the overall prevalence and incidence of epilepsy are expected to rise.

The Eurostat statistics indicate that over one-fifth (21.1%) of the European population was aged 65 or more in 2022. According to an article published by UpToDate Inc. in August 2021, the incidence rate of epilepsy rises with age and is highest among patients aged 75 and above.

Therefore, due to the growing geriatric population, there is notable surge in conditions such as epilepsy owing to which the market for epilepsy drugs witnesses a significant growth.

Europe Epilepsy Drugs Market Overview

The Europe epilepsy drugs market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The region holds a significant market share in the epilepsy drugs market. The European epilepsy drugs market is expected to witness significant growth during the forecast period due to factors such as the significant growth in elderly population, approvals of new drugs by regulatory authorities, increase in funding by governments to improve and develop effective drugs and treatments for seizures in the region.

Europe Epilepsy Drugs Market Revenue and Forecast to 2030 (US$ Million)

Europe Epilepsy Drugs Market Segmentation

The Europe epilepsy drugs market is segmented into treatment, distribution channel, and country.

Based on treatment, the Europe epilepsy drugs market is classified into first generation anti-epileptics, second generation anti-epileptics, and third generation anti-epileptics. The third-generation anti-epileptics segment held the largest share in 2022.

In terms of distribution channel, the Europe epilepsy drugs market is categorized into hospital pharmacy, retail pharmacy stores, and others. The hospital pharmacy segment held the largest share in 2022.

Based on country, the Europe epilepsy drugs market is segmented Germany, the UK, France, Italy, Spain, and the Rest of Europe. The UK dominated the Europe epilepsy drugs market in 2022.

Abbott Laboratories, Alkem Laboratories Ltd, GSK Plc, Novartis AG, Pfizer Inc, Sanofi SA, Teva Pharmaceutical Industries Ltd, and UCB SA are some of the leading companies operating in the Europe epilepsy drugs market.

ページTOPに戻る


Table of Contents

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Epilepsy Drugs Landscape
4.1 Overview
5. Europe Epilepsy Drugs Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Growing Prevalence of Epilepsy
5.1.2 Increasing Number of Elderly People
5.2 Market Restraints
5.2.1 Recall of Therapeutic Products
5.3 Market Opportunities
5.3.1 Several Epilepsy Drugs Nearing Patent Expiration
5.4 Future Trends
5.4.1 Increasing Product Approvals
5.5 Impact Analysis
6. Epilepsy Drugs Market - Europe Market Analysis
6.1 Overview
6.2 Europe Epilepsy Drugs Market Revenue (US$ Mn), 2022 - 2030
7. Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 - by Treatment
7.1 Overview
7.2 Europe Epilepsy Drugs Market Revenue Share, by Treatment 2022 & 2030 (%)
7.3 First Generation Antiepileptics
7.3.1 Overview
7.3.2 First Generation Antiepileptics: Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Second Generation Anti-epileptics
7.4.1 Overview
7.4.2 Second Generation Anti-epileptics: Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Third Generation Anti-epileptics
7.5.1 Overview
7.5.2 Third Generation Anti-epileptics: Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 - by Distribution Channel
8.1 Overview
8.2 Europe Epilepsy Drugs Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Hospital Pharmacy
8.3.1 Overview
8.3.2 Hospital Pharmacy: Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Retail Pharmacy Stores
8.4.1 Overview
8.4.2 Retail Pharmacy Stores: Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 - Country Analysis
9.1 Europe Epilepsy Drugs Market, by Key Country - Revenue (2022) (US$ Million)
9.1.1 Europe Epilepsy Drugs Market, by Country, 2022 & 2030 (%)
9.1.1.1 Germany: Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.1.1 Overview
9.1.1.1.2 Germany: Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.1.3 Germany: Europe Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.1.1.1.4 Germany: Europe Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.2 France: Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.2.1 Overview
9.1.1.2.2 France: Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.2.3 France: Europe Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.1.1.2.4 France: Europe Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.3 UK: Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.3.1 Overview
9.1.1.3.2 UK: Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.3.3 UK: Europe Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.1.1.3.4 UK: Europe Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.4 Italy: Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.4.1 Overview
9.1.1.4.2 Italy: Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.4.3 Italy: Europe Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.1.1.4.4 Italy: Europe Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.5 Spain: Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.5.1 Overview
9.1.1.5.2 Spain: Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.5.3 Spain: Europe Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.1.1.5.4 Spain: Europe Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.6 Rest of Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.6.1 Overview
9.1.1.6.2 Rest of Europe Epilepsy Drugs Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.6.3 Rest of Europe Epilepsy Drugs Market, by Treatment, 2020-2030 (US$ Million)
9.1.1.6.4 Rest of Europe Epilepsy Drugs Market, by Distribution Channel, 2020-2030 (US$ Million)
10. Epilepsy Drugs Market-Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Epilepsy Drugs Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 UCB SA
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Novartis AG
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Pfizer Inc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 GSK Plc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Abbott Laboratories
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Sanofi SA
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Teva Pharmaceutical Industries Ltd
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Alkem Laboratories Ltd
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

The Insight Partners社の製薬分野での最新刊レポート

本レポートと同じKEY WORD(distribution channel)の最新刊レポート


よくあるご質問


The Insight Partners社はどのような調査会社ですか?


The Insight Partnersはインドに本社を置く調査会社です。経験豊富な専門家チームを通じて、お客様に最適な調査と分析を提供することに専念しています。幅広い分野をカバーしていますがヘルスケ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/23 10:26

157.72 円

164.94 円

201.11 円

ページTOPに戻る